These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 3125812)
21. [Electrophysiological effects of flecainide on stimulus-inducible ventricular tachycardia]. Breithardt G; Borggrefe M; Yeh HL; Seipel L Z Kardiol; 1982 Apr; 71(4):278-83. PubMed ID: 7090468 [TBL] [Abstract][Full Text] [Related]
22. [Therapy of ventricular tachyarrhythmias refractory to lidocaine with propafenone (author's transl)]. Laimer H; Glogar D; Zilcher H Acta Med Austriaca; 1981; 8(5):140-4. PubMed ID: 7331741 [TBL] [Abstract][Full Text] [Related]
23. Out-of-hospital cardiac arrest in patients with no overt heart disease: electrophysiologic observations and clinical outcome. Bhandari AK; Hong R; Au P; McKay CR; Rahimtoola SH Can J Cardiol; 1988 Mar; 4(2):80-4. PubMed ID: 3365601 [TBL] [Abstract][Full Text] [Related]
24. [Value of provocation tests in the evaluation of the treatment of ventricular tachycardias with amiodarone]. Cassagneau B; Calazel J; Puel J; Massabuau P; Tournadre P; Fauvel JM; Bounhoure JP; Marin T; Narula OS Arch Mal Coeur Vaiss; 1984 Jul; 77(7):766-72. PubMed ID: 6433839 [TBL] [Abstract][Full Text] [Related]
28. Acute and long-term efficacy of propafenone in patients with sustained ventricular tachyarrhythmias: assessment with programmed ventricular stimulation. Podczeck A; Frohner K; Hief C; Stix G; Steinbach KK Eur Heart J; 1991 Jul; 12(7):796-9. PubMed ID: 1889445 [TBL] [Abstract][Full Text] [Related]
29. The use of associated propafenone in patients with amiodarone-resistant ventricular tachycardia. Morgera T; Dreas L; Humar F; Maras P; Chersevani D; Camerini F Int J Cardiol; 1991 May; 31(2):187-97. PubMed ID: 1869328 [TBL] [Abstract][Full Text] [Related]
30. [Long-term study of propafenone in severe ventricular extrasystole in elderly subjects]. Escande M; Diadema B; Maarek-Charbit M Ann Cardiol Angeiol (Paris); 1989 Nov; 38(9):555-60. PubMed ID: 2481423 [TBL] [Abstract][Full Text] [Related]
36. [Medium term study of the efficacy of propafenone in the treatment of hyperkinetic ventricular arrhythmia]. Cairo GF; Zanni PP; Mascelli G; Zangara A Clin Ter; 1989 Jun; 129(5):353-7. PubMed ID: 2527666 [TBL] [Abstract][Full Text] [Related]
37. Oral propafenone therapy for children with arrhythmias: efficacy and adverse effects in midterm follow-up. Guccione P; Drago F; Di Donato RM; Cicini MP; Pasquini L; Marino B; Marcelletti C; Ragonese P Am Heart J; 1991 Oct; 122(4 Pt 1):1022-7. PubMed ID: 1927853 [TBL] [Abstract][Full Text] [Related]
38. The mechanism of propafenone-induced slowing of ventricular tachycardia in man as defined by analysis of resetting response patterns. Callans DJ; Hook BG; Josephson ME Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 2):2035-41. PubMed ID: 1721220 [TBL] [Abstract][Full Text] [Related]
39. Aggravation of electrically provoked ventricular tachycardia during treatment with propafenone. Stavens CS; McGovern B; Garan H; Ruskin JN Am Heart J; 1985 Jul; 110(1 Pt 1):24-9. PubMed ID: 4013986 [TBL] [Abstract][Full Text] [Related]
40. The use of propafenone in the treatment of tachyarrhythmias in children. Vignati G; Mauri L; Figini A Eur Heart J; 1993 Apr; 14(4):546-50. PubMed ID: 8472721 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]